Warwick Innovations delivers knowledge exchange and
commercialisation services across the University of Warwick

We support University researchers in producing economic and societal impact from world-leading research.
This includes providing technology transfer services for the Science and Medicine Faculties as well as supporting innovation
in the arts, humanities and social sciences.


Poolbeg Pharma licences first-in-class broad spectrum
RNA-based immunotherapy for respiratory virus infections
from the University of Warwick.

Potentially helping to treat influenza, respiratory syncytial
virus (RSV), SARS-CoV-2 and others.

How do we support?

Our role is to guide innovators throughout the process of generating impact and a commercial return from their research,
whilst they maintain their academic focus.

We work closely with industry. Our specialist staff provide businesses and investors with access to the best of the University’s Intellectual Property. We support technology development, license IP and create spin-out companies that retain close ties to the University’s expertise. Our innovations span a wide range of technologies and sectors, and new innovations emerge every week.


(Innovation to Commercialisation of University Research)

Designed for research teams from all UK universities
with commercially-promising ideas, with potential funding
of up to £30k!